Comprehensive Notes: Molecular Biology and Genetics (Explorations, 2nd Edition)

Cells, Biomolecules, and Cellular Architecture

  • Four basic biomolecule types essential for cell structure and function: proteins, lipids, carbohydrates, and nucleic acids (DNA, RNA).
    • Proteins: shape, signaling, intracellular responses; categories include structural proteins (collagen, keratin, lactase, hemoglobin, membrane proteins), defense proteins (antibodies), enzymes (lactase), hormones (insulin), motor proteins (actin); form complex 3D shapes critical to function.
    • Lipids: include fats stored as energy, serve as hormones; phospholipids form the cell membrane bilayer; hydrophilic (water-loving) heads and hydrophobic (water-repelling) tails.
    • Carbohydrates: energy sources (glucose, starches); sugars provide cellular energy.
    • Nucleic acids: DNA and RNA; store and transmit genetic information; DNA is the blueprint; RNA mediates protein production and regulation.
  • Cells and cell types:
    • All life is built from cells; cellular life is characterized by two main cell types: prokaryotes and eukaryotes (Figure 3.2).
    • Prokaryotes (bacteria, archaea): single cells; DNA and organelles are not enclosed by membranes; no true compartments.
    • Eukaryotes: have membrane-bound organelles and a nucleus containing DNA; can be single- or multi-cellular (e.g., yeasts are single-celled; plants and animals are multi-cellular).
  • Human microbiome and health:
    • Not all bacteria are harmful; beneficial microbiota aid digestion, immune function, vitamin production (e.g., B12, K); microbiome links to health and disease.
    • Ancient biomolecules can be preserved on artifacts; modern techniques allow studying ancient biomolecules to illuminate the human past.
  • Cellular membranes and organelles (overview):
    • Cell membrane: phospholipid bilayer with embedded proteins; regulates molecule and ion passage (e.g., H2O, Na+).
    • Cytoplasm: jelly-like matrix containing organelles.
    • Organelles include nucleus (DNA location), mitochondria (ATP production), endoplasmic reticulum (ER; rough with ribosomes; smooth without), Golgi apparatus, lysosomes, centrioles, ribosomes, cytoskeleton components (microtubules).
    • Mitochondria: powerhouse producing ATP; contain their own DNA (mtDNA); variable numbers per cell depending on species/tissue; mitochondria are thought to have originated from symbiotic prokaryotes.
  • Nucleus and genetic organization:
    • DNA is organized in chromosomes within the nucleus; chromatin organization alternates between euchromatin (transcriptionally active) and heterochromatin (tightly packed, less accessible).
  • Key terminology and figures (referenced concepts):
    • DNA structure and base pairing; double helix; anti-parallel strands; nucleotide components; base pairs (A–T, C–G) held together by hydrogen bonds.
    • Chromosome organization and regulatory architecture; histones and nucleosome beads-on-a-string model; chromatin compaction into chromosomes.

DNA Structure, Genome Organization, and Nuclear Packaging

  • DNA architecture:
    • DNA is a double-stranded molecule with a sugar–phosphate backbone and four nucleotides: A, T, C, G.
    • Complementary base-pairing rules: A-TA\text{-}T and C-GC\text{-}G via hydrogen bonds; strands are antiparallel.
    • A DNA sequence is the order of bases along one strand; its complement is read on the opposite strand.
    • The human genome contains about 3×1093\times 10^9 base pairs; approximately three billion base pairs; roughly 20,000−25,00020{,}000-\text{25{,}000} protein-coding genes are distributed across chromosomes.
    • If a single cell’s DNA were stretched, it would measure about 2 meters2\text{ meters} (roughly 6.5 ft6.5\text{ ft}).
  • Packaging in the nucleus:
    • DNA is wrapped around histone proteins to form chromatin; beads-on-a-string structure forms nucleosomes.
    • Chromatin is further folded into chromosomes, enabling compact storage and organization during cell division.
    • Chromosomes can exist in euchromatin (loosely packed, transcriptionally active) or heterochromatin (tightly packed, mostly inactive).
  • Chromosome structure and numbering (humans):
    • Humans have 23 pairs23\ pairs of chromosomes, for a total of 4646 chromosomes per somatic cell.
    • One pair is the sex chromosomes: typically XX in females and XY in males.
    • Each chromosome has a centromere (center) and telomeres (ends) that protect chromosome integrity during replication and division.
    • Chromosome arms: long (q) arm and short (p) arm; centromere location defines these arms.
  • Chromosomal organization and signals for division:
    • Centromeres are essential during mitosis/meiosis for proper chromosome segregation.
    • Telomeres protect ends from degradation and shorten with each cell division; telomere maintenance relates to cellular aging and cancer biology.
  • Special topic illustration (Native American immunity and ancient DNA) underscores how modern and ancient DNA studies illuminate population history and immune adaptation.

DNA Replication and the Cell Cycle

  • DNA replication basics:
    • DNA replication is semi-conservative: each new double helix consists of one old (parent) strand and one new (daughter) strand.
    • Three steps of replication: initiation, elongation, termination.
    • Initiation: enzymes (e.g., helicase) unwind the DNA at replication forks; replication forks are active sites for copying DNA.
    • Elongation: leading strand is synthesized continuously; lagging strand is synthesized in short segments that are later joined.
    • Termination: replication ends at stop sequences and replication forks resolve.
    • Outcome: chromatids are duplicated, increasing genetic material for cell division while preserving parental information.
    • Mutation rate during replication: copying mistakes occur roughly every 1010 nucleotides; polymerases have proofreading to reduce errors.
  • Cell cycle and cell division:
    • Interphase: cell grows (G1), replicates DNA (S phase), and prepares for division (G2); metabolism and energy production increase.
    • Checkpoints regulate progression; failures can trigger apoptosis (programmed cell death).
    • Mitosis: somatic cell division producing two diploid daughter cells; aligns chromosomes at the center, then separates sister chromatids to opposite poles; results in two cells with n=46n=46 chromosomes each (diploid).
    • Meiosis: gamete formation; two rounds of division yield four haploid cells (gametes) with n=23n=23 chromosomes each; genetic recombination occurs during meiosis I via crossing over of homologous chromosomes.
    • Diploid versus haploid: diploid (2n) cells contain two sets of chromosomes; haploid (n) contain one set.
  • Homologous chromosomes and sister chromatids:
    • Homologous chromosomes: paired chromosomes (one from each parent) that carry the same genes in the same loci but possibly different alleles.
    • Sister chromatids: identical copies produced during DNA replication that are held together at the centromere until separation.
  • Male/female chromosomal composition and sex determination:
    • Female: XX; male: XY.
    • In many cells, sex chromosome composition affects inheritance patterns in pedigrees.
  • Chromosomal disorders: aneuploidies
    • Aneuploidy: abnormal chromosome number due to errors in meiosis or mitosis (e.g., trisomy 21 Down syndrome; XXX, XXY, XO sex chromosome variations).
    • Aneuploid cells are often detrimental and can cause embryonic loss or live birth with disorders.
  • Cancer and the cell cycle:
    • Unchecked cell cycle progression is a hallmark of cancer; cancer cells can bypass normal checkpoints and telomere maintenance contributes to replicative immortality.
    • HeLa cells: historic immortal cell line derived from Henrietta Lacks (1955); demonstrates ethical issues of consent and use of human tissues in research.
    • Therapies target cell cycle progression or telomere biology to limit cancer cell division.

Protein Synthesis: Transcription and Translation

  • Overview of gene expression:
    • Genes encode for RNA and ultimately proteins; transcription copies DNA into RNA; translation converts RNA codons into a polypeptide chain of amino acids.
    • DNA is transcribed into messenger RNA (mRNA); translation occurs at ribosomes in the cytoplasm (or on rough ER).
  • Transcription details:
    • RNA polymerase reads a DNA gene (template strand) to synthesize a complementary RNA strand.
    • RNA is single-stranded; RNA nucleotides include A, U, C, G (uracil replaces thymine).
    • Introns (noncoding) are removed during splicing; exons (coding) are joined to form mature mRNA.
    • Transcription factors bind promoters to regulate transcription; promoter regions influence whether a gene is turned on or off.
    • Example transcription sequence: DNA template TACGGATGC -> mRNA AUGCCUACG (illustrative).
  • Translation details:
    • Mature mRNA exits the nucleus and binds to a ribosome; codons (triplets) on the mRNA specify amino acids via tRNA adapters.
    • Start codon: AUGAUG (codes for Methionine, Met) and often initiates translation in eukaryotes.
    • Stop codons: UAA,UAG,UGAUAA, UAG, UGA terminate translation.
    • There are 20 standard amino acids; codons map to amino acids via the genetic code (codon table).
    • Translation proceeds with tRNA delivering amino acids to the growing polypeptide chain; the sequence of amino acids folds into a functional protein.
    • Example: mRNA AUG-CCU-ACG encodes Met-Pro-Thr.
  • RNA processing and gene structure:
    • Genes contain exons and introns; post-transcription, introns are removed and exons are joined to form mature mRNA.
    • Spliceosome complex responsible for intron removal and exon ligation.
  • Lactase (LCT) gene: a model of transcriptional regulation of protein synthesis
    • LCT promoter region controls transcription; transcription factor binding initiates RNA polymerase recruitment.
    • LCT pre-mRNA is processed; mature LCT mRNA translated into the lactase enzyme.
    • Lactase persistence (adult lactase production) arises from mutations enabling continuous transcription; historical prevalence in pastoral populations (Europe, North Africa).

Mendelian Genetics, Inheritance Patterns, and Pedigrees

  • Mendel and Mendelian genetics:
    • Gregor Mendel (1822–1884) established laws of inheritance through pea plant studies.
    • Dominant vs recessive traits: dominant requires only one copy to affect phenotype; recessive requires two copies for expression.
    • Genotype vs phenotype: genotype is the two alleles (e.g., BB, Bb, bb); phenotype is observed trait (e.g., purple vs white flowers).
    • Alleles are gene copies at the same locus on homologous chromosomes; alleles may differ in sequence and phenotype.
    • Law of segregation: during gamete formation (meiosis), two alleles segregate so that offspring inherit one allele from each parent.
  • Visualization with Punnett squares:
    • Punnett squares predict genotype and phenotype ratios for crosses with known parental genotypes.
    • Example: Bb x Bb yields BB, Bb, bb genotypes with corresponding phenotypes depending on dominance.
  • Mendelian traits in humans:
    • Some human diseases follow simple Mendelian inheritance; although human reproduction is limited, patterns can be inferred in pedigrees.
  • ABO blood group system (Mendelian example with codominance):
    • Alleles: A, B (dominant), and O (recessive); A and B are codominant; AB shows both antigens.
    • Blood type genotypes: AA, AB, AO, BB, BO, OO; phenotypes: A, B, AB, O.
    • Antigens on red blood cells determine antibodies in plasma; antibodies target incompatible antigens, leading to agglutination if mismatched.
  • Rh factor (D antigen):
    • Rh+ indicates presence of Rh antigen; Rh- indicates absence.
    • Rh status is inherited independently of ABO and can affect pregnancy (Rh incompatibility risk; treatment may be required).
    • All statuses can be positive or negative: O+, A+, B+, AB+; O-, A-, B-, AB- (universal donor/recipient concepts explained).
  • Pedigree analysis and inheritance patterns:
    • Pedigrees map family history to assess whether a trait is autosomal dominant, autosomal recessive, or X-linked.
    • Autosomal dominant: at least one affected parent; trait appears in every generation (e.g., Huntington’s disease).
    • Autosomal recessive: carriers (heterozygotes) may be asymptomatic; trait can skip generations (e.g., Cystic Fibrosis).
    • X-linked recessive: more males affected; mothers carriers have 50% affected sons if father unaffected; daughters may be carriers.
    • X-linked dominant: affected males pass to all daughters but not to sons; affected females pass to both sons and daughters (pattern changes with specific conditions).
  • Other patterns and concepts:
    • Incomplete dominance: heterozygote phenotype is intermediate (e.g., pink flowers in snapdragon Rr x Rr with red RR and white rr).
    • Penetrance: proportion of individuals with a genotype who express the phenotype; complete penetrance means all with genotype express phenotype.
    • Example of incomplete penetrance: HEXA mutations and Tay-Sachs carrier status; BRCA1/BRCA2 penetrance varies with environment and lifestyle.
    • Polygenic traits: many genes contribute to a trait; examples include height, hair color, eye color, and skin pigmentation; environment and lifestyle also influence expression.
  • Complex diseases and genomics:
    • Many common diseases are polygenic and multifactorial (e.g., Type II diabetes, cardiovascular disease, schizophrenia).
    • Genomic studies (GWAS) identify loci associated with complex traits; large sample sizes and diverse populations improve accuracy.
    • Epistasis, gene regulation, and environment contribute to trait expression and disease risk.

Genomics, Epigenetics, and X Chromosome Inactivation

  • The genome and coding vs noncoding DNA:
    • The human genome contains about 2−3×1092-3\times 10^9 base pairs across 23 chromosome pairs; roughly 20k–25k protein-coding genes.
    • A large portion of the genome is noncoding; previously labeled as junk DNA, now understood to regulate gene expression and genome structure.
    • Regulatory elements (promoters, enhancers) influence when and where genes are turned on or off.
  • Genomics and regulation:
    • Genomics studies gene structure, evolution, and regulation; noncoding regions can influence gene expression and disease risk.
    • GWAS identifies variants associated with complex traits; meta-analysis across populations enhances discovery.
    • Ethnic diversity in genomic studies is crucial for accurate risk assessment across populations.
  • Epigenetics and gene regulation:
    • Epigenetics involves heritable changes in gene expression without changes to the DNA sequence itself; mechanisms include DNA methylation and histone modifications.
    • DNA methylation (adding methyl groups, —CH3) tends to suppress transcription when present at promoter or regulatory regions.
    • Histone modifications can tighten or loosen chromatin structure, affecting gene accessibility for transcription.
    • Epigenetic changes can be reversible and influenced by environment; some changes can be inherited across generations.
    • Aging and environmental stressors can alter epigenetic marks; identical twins diverge epigenetically with age.
  • X chromosome inactivation (Lyon hypothesis):
    • In female mammals, one X chromosome is randomly inactivated in each cell during early development, led by XIST RNA and epigenetic mechanisms.
    • Result: females have a mosaic of cells expressing genes from either the maternal or paternal X chromosome, evident in calico cats and similar patterns in humans.
    • X inactivation ensures dosage compensation between XX females and XY males.
  • Epigenetics and X inactivation in health and disease:
    • Epigenetic regulation plays a role in development, aging, cancer, and response to environmental factors.
    • Therapeutic strategies seek to modulate epigenetic marks (e.g., DNA methylation, histone acetylation) to treat diseases; epigenetic changes can be targeted by drugs.
  • Genomics and personalized medicine:
    • Precision medicine uses genomic and epigenomic information to tailor therapies to individuals (e.g., targeting regulatory regions, pharmacogenomics).
    • Advances in sequencing (NGS) enable whole-genome, exome, and transcriptome analyses; multi-omics approaches integrate DNA, RNA, and protein data.

Genetic Testing, Biotechnology, and Bioethics

  • Newborn screening and clinical testing:
    • Newborn screening has been standard in the U.S. for over 50 years to detect treatable genetic disorders (e.g., phenylketonuria, PKU).
    • CLIA: Clinical Laboratory Improvement Amendments set federal standards for lab testing accuracy in clinical settings.
    • Genetic counseling is often offered to interpret results and guide medical decisions.
  • Direct-to-consumer (DTC) genetic testing:
    • DTC testing provides consumer access to genetic information without medical professional guidance.
    • Common uses include health risk reports, ancestry estimates, and lifestyle-oriented reports; some reports may require professional interpretation.
    • Regulation and oversight have evolved; 23andMe faced FDA regulation for certain health-related reports; ongoing debates about consumer risk, privacy, and psychological impact.
    • Ancestry testing may spark identity questions and raise concerns about the interpretation and relevance of population labels.
  • Forensic and privacy concerns:
    • Genomic databases can be used for law enforcement purposes; ethical considerations include consent, data security, and potential misuse.
  • Medical genetics and counseling:
    • Genetic testing can identify carriers, inform reproductive choices, and guide treatment (e.g., pharmacogenomics, BRCA1/BRCA2 testing).
    • Counseling helps individuals understand probabilistic risk, penetrance, and how lifestyle factors interact with genetic risk.
  • Technologies transforming genetics:
    • Polymerase chain reaction (PCR) amplifies DNA; Kary Mullis developed PCR in 1985, enabling DNA analysis from small templates.
    • Sanger sequencing: chain-termination sequencing used to read DNA sequence with fluorescent labels.
    • Microarrays (genotyping arrays) detect known variants by hybridization on chips; fluorescence indicates presence/absence of alleles.
    • Next-generation sequencing (NGS): high-throughput sequencing that can read millions of bases in parallel; enables whole-genome sequencing (WGS) or exome sequencing (coding regions only).
    • RNA sequencing (transcriptomics) helps understand gene expression and regulation in different tissues or disease states.
  • Multi-omics and personalized therapy:
    • Multi-omics integrates genomics, transcriptomics, proteomics, and other data to guide personalized treatment strategies.
    • Tumor sequencing and transcriptome analysis guide oncology therapies and target discovery.
  • Ethical, philosophical, and practical implications:
    • Benefits include early disease detection, informed family planning, and personalized medicine.
    • Drawbacks include privacy concerns, psychological burden from uncertain or incidental findings, potential discrimination, and unequal access to technologies.
    • Debates about direct access to genetic information without professional counseling; importance of informed consent and appropriate interpretation.
    • The line between medical use and entertainment/marketing in genetic testing raises questions about responsibility and regulation.

Protein Synthesis, Epigenetics, and Regulation in Practice

  • Codon-to-amino-acid mapping and the genetic code:
    • The genetic code translates RNA codons (triplets) into amino acids; 20 standard amino acids encoded by 64 codons.
    • Start codon (AUG) initiates translation; stop codons (UAA, UAG, UGA) terminate translation.
    • Codon-anticodon interaction via tRNA delivers amino acids to the ribosome for polypeptide assembly.
  • Bioethics and personal decision-making (reflective prompts from the chapter):
    • Questions about how individuals should respond to incidental findings (e.g., late-onset Alzheimer’s risk) and the trade-offs of knowing versus not knowing.
    • Considerations of maternal/paternal inheritance, penetrance, and environmental influences on gene expression when making medical decisions.

Implications for Anthropology and Real-World Relevance

  • Understanding human variation:
    • Genetic and epigenetic mechanisms explain part of the variation seen in humans today, including phenotypes like hair color, lactose tolerance, disease susceptibility, and responses to environmental pressures.
    • Ancient DNA studies illuminate past migrations, immune adaptations (e.g., HLA-DQA1 allele frequencies in Tsimshian populations), and how historical events shaped modern genomes.
  • Ethical and social implications:
    • Bioethics concerns in genetic testing include privacy, potential discrimination, and how information is used (clinical vs consumer contexts).
    • Anthropologists consider how genetics interacts with culture, history, identity, and public health, recognizing the limitations of genetic determinism.

Quick Recap of Key Concepts and Formulas

  • Base pairing:
    • A-TandC-GA\text{-}T\quad\text{and}\quad C\text{-}G
  • DNA length in humans:
    • ≈3×109\approx 3\times 10^9 base pairs per genome; stretched length ≈2 m\approx 2\text{ m} per cell.
  • Chromosome numbers:
    • Humans: 46 chromosomes46\text{ chromosomes}, 23 pairs23\text{ pairs}; sex chromosomes: XX (female),XY (male)XX\ (female), XY\ (male).
  • DNA replication outcomes:
    • Semi-conservative replication yields two double-stranded DNA molecules, each with one parent and one daughter strand.
  • Start/stop codons:
    • Start: AUGAUG; Stop: UAA, UAG, UGAUAA, \, UAG, \, UGA.
  • Inheritance basics:
    • Autosomal dominant/recessive patterns; X-linked patterns; codominance (e.g., ABO system).
  • Epigenetics:
    • DNA methylation: −CH3-CH_3 addition suppresses transcription at regulatory regions.
    • Histone modifications regulate chromatin compaction and gene accessibility.
  • Technologies:
    • PCR, Sanger sequencing, microarrays, and next-generation sequencing (NGS) with whole-genome/exome/transcriptome applications.
  • Ethical and societal considerations:
    • DTC testing, newborn screening, CLIA regulation, genetic counselors, privacy, and the balance of benefits/risks in genetic information.

Practice Prompt Ideas (from Review Questions Section)

  • Describe the purpose of DNA replication and outline its three main stages: initiation, elongation, termination.
  • Explain when DNA mutations occur and how they contribute to phenotypic variation.
  • Define homologous chromosomes and sister chromatids and describe their roles in meiosis and mitosis.
  • Compare the major differences between mitosis and meiosis in terms of chromosome number, genetic diversity, and offspring cell types.
  • Determine the pattern of inheritance for a given pedigree (autosomal dominant, autosomal recessive, or X-linked recessive) and justify the genotype annotations.
  • Transcribe a DNA sequence to mRNA and translate the mRNA to a peptide using the codon table; discuss the significance of the first and last codons.
  • Evaluate benefits and drawbacks of direct-to-consumer genetic testing and discuss ethical considerations.

Key Terms (Selected from the Glossary)

  • Allele, Autosome, Base pairs, Codominance, Chromatin, Chromosome, DNA methylation, Epigenetics, Exon, Gene, Genotype, Phenotype, Promoter, RNA polymerase, rRNA, mRNA, tRNA, Codons, Start codon, Stop codons, Translation, Transcription, Haploid, Diploid, Meiosis, Mitosis, Pedigree, Aneuploidy, Down syndrome, BRCA1/BRCA2, Penetrance, GWAS, Epigenetics, XIST, Lyon hypothesis, X chromosome inactivation, HLA-DQA1, mtDNA, PCR, Sanger sequencing, Microarray, NGS, Exome, Transcriptome, Multi-omics

Notes on Figures and Topics Mentioned (to Aid quick lookup)

  • Figure references cover: biomolecule table (3.1), prokaryote vs eukaryote (3.2), plant vs animal cells (3.3-3.5), organelles (3.5-3.9), cell membrane and cytoplasm, mitochondria, nucleus, chromatin and chromosomes (3.8-3.12), chromosome regions and centromeres/telomeres (3.10-3.13), euchromatin vs heterochromatin, DNA structure and the double helix (3.7-3.9).
  • Key historical notes: Franklin's X-ray crystallography image of DNA; Watson, Crick, and Wilkins Nobel Prize 1962; Rosalind Franklin's legacy.
  • Special Topic themes: Native American immunity and ancient DNA; HeLa cell line history; LCT lactase persistence; ABO and Rh blood types; various Mendelian and non-M Mendelian patterns; X inactivation in calico cats.

If you’d like, I can tailor these notes to a specific lecture slide set or create a condensed version focused on a subset (e.g., only Mendelian genetics and genetics testing ethics).